**Core Concept:** The triple test is a screening test used in clinical practice to assess the risk of an individual developing a certain disease. In the context of this question, the disease is Down syndrome or trisomy 21, a genetic disorder. The triple test typically includes alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (beta-hCG), and estriol (E3) levels in a pregnant woman's blood sample. These markers are measured because elevated levels may indicate aneuploidy, particularly trisomy 21.

**Why the Correct Answer is Right:** The correct answer, **D**, is "Ultrasound screening," which is used to evaluate the fetus and identify structural abnormalities, not biochemical markers. Ultrasound screening does not involve measuring the levels of AFP, beta-hCG, and estriol, which are the components of the triple test.

**Why Each Wrong Option is Incorrect:**

A. **Estriol (E3)** is a hormone involved in fetal development and plays a crucial role in the triple test. Elevated estriol levels are associated with increased risk of Down syndrome and other aneuploidies. Omission of estriol would make the triple test incomplete.

B. **Alpha-fetoprotein (AFP)** is another hormone involved in fetal development, particularly in the liver, gut, and central nervous system. Elevated AFP levels are linked to an increased risk of Down syndrome and neural tube defects. Omission of AFP would undermine the test's sensitivity for detecting Down syndrome.

C. **Beta-human chorionic gonadotropin (beta-hCG)** is a hormone secreted by the placenta and fetal trophoblasts. Elevated beta-hCG levels are associated with an increased risk of Down syndrome and other aneuploidies. Omission of beta-hCG would make the triple test less effective in screening for Down syndrome and other aneuploidies.

**Why the Correct Answer is Right:** The correct answer, **D**, is "Ultrasound screening". This option is right because ultrasound is a separate method of screening for Down syndrome, which is a part of the triple test. Ultrasound screening involves evaluating the fetus for structural abnormalities, which is not covered by the triple test, which focuses on biochemical markers (AFP, beta-hCG, and estriol) in maternal blood.

**Why Each Wrong Option is Incorrect:**

A. **Alpha-fetoprotein (AFP)** is a hormone involved in fetal development, particularly in the liver, gut, and central nervous system. Ultrasound screening does not measure AFP levels, so option A is incorrect.

B. **Beta-human chorionic gonadotropin (beta-hCG)** is a hormone secreted by the placenta and fetal trophoblasts. Ultrasound screening does not measure beta-hCG levels, so option B is incorrect.

C. **Estriol (E3)** is a hormone involved in fetal development, particularly in the brain, liver, and placenta. Ul